XClose

UCL Cancer Institute

Home
Menu

MSc Cancer

Applications for September 2019 entry will open in October. Samuel Fund scholarships of £5,000 and £25,000 will be available for 2019.

The Cancer MSc reflects the depth and breadth of research interests, from basic science to translational medicine, within the UCL Cancer Institute. The programme, taught by research scientists and academic clinicians, provides students with an in-depth look at the biology behind the disease processes which lead to cancer.

Students will learn about the approaches taken to predict, detect, monitor, and treat cancer. The programme provides a strong grounding in the cutting edge research methods and techniques used to advance our understanding of this disease and design better treatment strategies.

The programme is designed for those with undergraduate qualifications in the life sciences, scientists, clinicians, and other healthcare professionals including individuals from the pharmaceutical and biotech industries. The knowledge and transferable skills developed in the course will be suitable for those in an industrial or healthcare setting, as well as those individuals contemplating further PhD or medical studies. 

Student Christian Pellegrino talks about why he chose MSc Cancer: 

MediaCentral Widget Placeholderhttps://mediacentral.ucl.ac.uk/Player/2071

Student Georgia Constaninou on her experience studying MSc Cancer at UCL: 

YouTube Widget Placeholderhttps://www.youtube.com/watch?v=KLcHjVqUQlA

 

Why study with us? 

University College London is one of Europe’s largest and most productive centres of biomedical science with great strengths in cancer research. Scientists at UCL have an international reputation for leading basic, translational and clinical cancer research. The UCL Cancer Institute brings together scientists from various disciplines to synergise multidisciplinary research into cancer. Our researchers’ particular areas of expertise include:

  • the biology of leukaemia
  • the infectious causes of cancer
  • the design of drugs that interact with DNA
  • antibody-directed therapies
  • the molecular pathology of cancer
  • epigenetic changes in cancer
  • gene therapy
  • early phase clinical trials
  • national and international clinical trials in solid tumours and blood cancers

In addition we collaborate with scientists in nanotechnology, bioinformatics and computational sciences, developmental biology, stem-cell research, immunity, engineering and medicinal chemistry.


Entry Requirements

A minimum of an upper second-class Honours degree in a relevant discipline from a UK university or an overseas qualification of an equivalent standard, or an appropriate professional qualification or work experience.


How To Apply

Applications deadline: Friday 27 July 2018 for the 2018-19 academic year (September 2018 start). See online prospectus entry for MSc Cancer.

Applications for September 2019 start will open autumn 2019. All applications should be submitted directly to UCL admissions

View prospectus application


Fees and Funding

Home/EU: £14,180 (2018/19) full-time
Overseas: £26,670  (2018/19) full-time

UCL tuition fees information

For those students working to organise scholarship funding (particularly overseas applicants), early application for admission is strongly encouraged.

The UK Government Postgraduate Loan Scheme is available to students applying to Master's programmes (eligibility criteria apply)

Please note, MSc Cancer Samuel Fund scholarships for 2018-19 entry have now closed.